Clinical Trial Update: EGCG Modulate the Cytotoxic Effects of Chemotherapeutic Agents in Human Urothelial Carcinoma Cells

View source ↗

Summary

This clinical trial update describes an in vitro study examining whether epigallocatechin gallate (EGCG) can modulate the cytotoxic effects of chemotherapeutic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma

Drugs mentioned

• EGCG (epigallocatechin gallate)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Urothelial Carcinoma | Status: UNKNOWN